International Journal of Molecular Medicine 2024

2 papers

Top Research Directions

The 5 research directions with International Journal of Molecular Medicine 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Coordinating Nrf2 Activation and NF-κB Suppression150.0%
2High-Fidelity Patient-Derived Organoid and Tumor Modeling150.0%
3Principles of Protein Expression Analysis via Western Blotting150.0%
4Reinforcing Epithelial Barriers via Tight Junction Protein Upregulation150.0%
5The Outside-In Path of Neurovascular Barrier Failure150.0%

Download all directions as CSV

Institutions

Institutions credited by International Journal of Molecular Medicine 2024 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1004eeze55 1100.0%

Download all institutions as CSV

About this data

Papers. International Journal of Molecular Medicine 2024 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Molecular Medicine 2024”, https://lacuna.tiptreesystems.com/venue/international-journal-of-molecular-medicine/2024.

Papers

Title
Anthrahydroquinone‑2,6‑disulfonate attenuates PQ‑induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of the PI3K/AKT/eNOS pathway
[Retracted] Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway